Ex-CEO Stole Trade Secrets, Drug Co. Says

Law360, New York (February 23, 2011, 2:23 PM EST) -- A biopharmaceutical startup sued its former CEO in New York state court Tuesday, claiming he breached employment agreements by canceling an important development meeting with Bristol-Myers Squibb Co. and running off with research records and samples.

NaniRx Therapeutics Inc. said David I. Cohen, a former co-chair of the National Institutes of Health's HIV vaccine development committee, acted unilaterally to undermine the company's research efforts and cost it millions of dollars, according to a complaint filed in the Supreme Court of the State of New York, County...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.